Cargando…
A study on catalytic and non-catalytic sites of H5N1 and H1N1 neuraminidase as the target for chalcone inhibitors
The H1N1 pandemic in 2009 and the H5N1 outbreak in 2005 have shocked the world as millions of people were infected and hundreds of thousands died due to the infections by the influenza virus. Oseltamivir, the most common drug to block the viral life cycle by inhibiting neuraminidase (NA) enzyme, has...
Autores principales: | Hariyono, Pandu, Kotta, Jasvidianto Chriza, Adhipandito, Christophorus Fideluno, Aprilianto, Eko, Candaya, Evan Julian, Wahab, Habibah A., Hariono, Maywan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445792/ https://www.ncbi.nlm.nih.gov/pubmed/34549099 http://dx.doi.org/10.1186/s13765-021-00639-w |
Ejemplares similares
-
Potential New H1N1 Neuraminidase Inhibitors from Ferulic Acid and Vanillin: Molecular Modelling, Synthesis and in Vitro Assay
por: Hariono, Maywan, et al.
Publicado: (2016) -
Medicinal Effect, In Silico Bioactivity Prediction, and Pharmaceutical Formulation of Ageratum conyzoides L.: A Review
por: Kotta, Jasvidianto C., et al.
Publicado: (2020) -
Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore studies
por: Hariono, Maywan, et al.
Publicado: (2021) -
An integrated virtual screening of compounds from Carica papaya leaves against multiple protein targets of SARS-Coronavirus-2
por: Hariyono, Pandu, et al.
Publicado: (2021) -
2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies
por: Hariyono, Pandu, et al.
Publicado: (2022)